Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1671 1686
This examiner grants 51% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17175425 | METHODS AND SYSTEMS FOR DETERMINING FUSION EVENTS | Non-Final OA | Guardant Health, Inc. |
| 17658284 | PLURIPOTENT STEM CELL MANUFACTURING SYSTEM | Final Rejection | Canon Kabushiki Kaisha |
| 17192530 | METHOD FOR GENERATING COMPOUND STRUCTURE, PROGRAM FOR GENERATING COMPOUND STRUCTURE, AND DEVICE FOR GENERATING COMPOUND STRUCTURE | Final Rejection | FUJIFILM Corporation |
| 17788304 | METHOD AND SYSTEM FOR OPTIMAL VACCINE DESIGN | Non-Final OA | NEC Corporation |
| 17768059 | DNA Copy Number Alterations (CNAs) to Determine Cancer Phenotypes | Non-Final OA | The University of North Carolina at Chapel Hill |
| 17175495 | DEEP LEARNING APPROACH TO CORRELATE CELLULAR MORPHOLOGY AND GENETICS | Non-Final OA | The Regents of the University of California |
| 17914279 | ATHLETIC PERFORMANCE ESTIMATION APPARATUS, ATHLETIC PERFORMANCE ESTIMATION METHOD, AND PROGRAM | Final Rejection | NTT, Inc. |
| 18151686 | T-CELL RECEPTOR OPTIMIZATION WITH REINFORCEMENT LEARNING AND MUTATION POLICIES FOR PRECISION IMMUNOTHERAPY | Non-Final OA | NEC Laboratories America, Inc. |
| 17793974 | GUIDED ANALYSIS OF SINGLE CELL SEQUENCING DATA USING BULK SEQUENCING DATA | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18047818 | TECHNOLOGIES FOR GENETIC ENGINEERING DETECTION | Non-Final OA | BATTELLE MEMORIAL INSTITUTE |
| 17833394 | METHODS AND SYSTEMS FOR IDENTIFYING RECOMBINANT VARIANTS | Non-Final OA | Illumina, Inc. |
| 17703958 | EFFICIENT VOXELIZATION FOR DEEP LEARNING | Non-Final OA | Illumina, Inc. |
| 17699053 | GENOME SEQUENCING AS AN ALTERNATIVE TO CYTOGENETIC ANALYSIS | Final Rejection | Washington University |
| 17756068 | SYSTEMS AND METHODS FOR CONTAMINATION DETECTION IN NEXT GENERATION SEQUENCING SAMPLES | Non-Final OA | Roche Sequencing Solutions, Inc. |
| 17929782 | Methods and Apparatuses for Estimating Parameters in a Predictive Model for Use in Sequencing-by-Synthesis | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy